NASDAQ:FCSC - Fibrocell Science Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.00
+0 (0.00%)
Get New Fibrocell Science Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FCSC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FCSC

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Fibrocell Science in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -100.00% upside from the last price of $3.00.

This chart shows the closing price for FCSC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Fibrocell Science. This rating has held steady since September 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/13/2019HC WainwrightDowngradeBuy ➝ Neutral$3.00High
8/16/2019HC WainwrightReiterated RatingBuy$20.00Medium
3/28/2019HC WainwrightReiterated RatingBuy$22.00High
11/13/2018HC WainwrightReiterated RatingBuy$22.00Low
8/9/2018HC WainwrightSet Price TargetBuy$22.00High
6/5/2018HC WainwrightReiterated RatingBuy$22.00Low
5/10/2018HC WainwrightSet Price TargetBuy$30.00High
4/2/2018Griffin SecuritiesReiterated RatingBuyLow
3/19/2018HC WainwrightSet Price TargetBuy$30.00Medium
3/6/2018HC WainwrightReiterated RatingBuy$30.00High
1/30/2018HC WainwrightSet Price TargetBuy$30.00High
1/16/2018HC WainwrightSet Price TargetBuy$38.00 ➝ $30.00High
10/5/2017HC WainwrightReiterated RatingBuy$38.00N/A
9/26/2017HC WainwrightBoost Price TargetBuy ➝ Buy$28.50 ➝ $38.00High
9/15/2017HC WainwrightReiterated RatingBuy$28.50High
8/9/2017HC WainwrightSet Price TargetBuy$30.00Medium
(Data available from 7/5/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/6/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/6/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Fibrocell Science logo
Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on discovering and developing therapies for diseases affecting the skin and connective tissues in the United States. The company's gene therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, a gene therapy for localized scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions. It has collaboration agreement with Intrexon Corporation for the development of FCX-007, FCX-013, and products for the treatment of chronic inflammation and degenerative diseases of human joints. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was incorporated in 1992 and is based in Exton, Pennsylvania.
Read More

Today's Range

Now: $3.00
Low: $3.00
High: $3.00

50 Day Range

MA: $3.00
Low: $3.00
High: $3.00

52 Week Range

Now: $3.00
Low: $1.45
High: $3.28

Volume

N/A

Average Volume

78,673 shs

Market Capitalization

$29.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67

Frequently Asked Questions

What sell-side analysts currently cover shares of Fibrocell Science?

The following Wall Street sell-side analysts have issued stock ratings on Fibrocell Science in the last twelve months:
View the latest analyst ratings for FCSC.

What is the current price target for Fibrocell Science?

0 Wall Street analysts have set twelve-month price targets for Fibrocell Science in the last year.
View the latest price targets for FCSC.

What is the current consensus analyst rating for Fibrocell Science?

Fibrocell Science currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for FCSC.

How do I contact Fibrocell Science's investor relations team?

Fibrocell Science's physical mailing address is 405 EAGLEVIEW BOULEVARD, EXTON PA, 19341. The company's listed phone number is 484-713-6000 and its investor relations email address is [email protected] The official website for Fibrocell Science is fibrocell.com. Learn More about contacing Fibrocell Science investor relations.